National Comprehensive Cancer Network

About NCCN

Leadership

Board of Directors

The NCCN Board of Directors is comprised of two representatives from each NCCN Member Institution who share in NCCN's mission to improve the quality, effectiveness, and efficiency of care provided to the patients whom they serve.


Samuel M. Silver, MD, PhD, MACP / Chair
University of Michigan Comprehensive Cancer Center

Timothy J. Eberlein, MD / Vice Chair
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Ray Lynch, CPA, MBA / Treasurer
Huntsman Cancer Institute at the University of Utah

Mara G. Bloom, JD, MS / Secretary
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Laura L. Adams
Stanford Cancer Institute

Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Douglas W. Blayney, MD
Stanford Cancer Institute

Jan C. Buckner, MD
Mayo Clinic Cancer Center

Rebecca L. Caires, MBA
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Carolyn C. Carpenter, MHA
Duke Cancer Institute

Peter R. Carroll, MD
UCSF Helen Diller Family Comprehensive Cancer Center

William E. Carson III, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Peter F. Coccia, MD
Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center

Thomas A. D'Amico, MD
Duke Cancer Institute

Paul F. Engstrom, MD, FACP
Fox Chase Cancer Center

David S. Ettinger, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Theresa J. Franco, RN, MSN
Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center

Ned Groves, MPS, PMP
Mayo Clinic Cancer Center

Lauren E. Hackett, MPA
Vanderbilt-Ingram Cancer Center

Mark F. Kochevar, MBA
University of Colorado Cancer Center

Larry E. Kun, MD
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

Razelle Kurzrock, MD
UC San Diego Moores Cancer Center

Terry S. Langbaum, MAS
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

G. Douglas Letson, MD
Moffitt Cancer Center

Trisha Lollo, MPH
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Abe Lopman, MBA
Yale Cancer Center/Smilow Cancer Hospital

Thomas J. Lynch, Jr., MD
Yale Cancer Center/Smilow Cancer Hospital

Joanne Mortimer, MD
City of Hope Comprehensive Cancer Center

Lisle M. Nabell, MD
University of Alabama at Birmingham Comprehensive Cancer Center

Paul J. Nelson, MBA
Memorial Sloan Kettering Cancer Center

Michael N. Neuss, MD
Vanderbilt-Ingram Cancer Center

Patrick J. O`Brien, MBA
Fox Chase Cancer Center

Barbara Parker, MD
UC San Diego Moores Cancer Center

David G. Pfister, MD
Memorial Sloan Kettering Cancer Center

Anthony Picone, MD, PhD, MBA
Roswell Park Cancer Institute

Dorothy E. Puhy, MBA
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

W. Thomas Purcell, MD, MBA
University of Colorado Cancer Center

Marty Sargeant, MBA
City of Hope Comprehensive Cancer Center

Lee S. Schwartzberg, MD, FACP
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

Gerrie Shields, MBA
UCSF Helen Diller Family Comprehensive Cancer Center

Warren Smedley, MSHA
University of Alabama at Birmingham Comprehensive Cancer Center

F. Marc Stewart, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

John W. Sweetenham, MD
Huntsman Cancer Institute at the University of Utah

Myra Tanita
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Donald L. Trump, MD
Roswell Park Cancer Institute

The Honorable Ellen O. Tauscher
Chair, NCCN Foundation Board of Directors

Braulio Vicente, Jr., MBA
Moffitt Cancer Center

Marcy B. Waldinger, MHSA
University of Michigan Comprehensive Cancer Center

Jeff A. Walker, MBA
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Ronald S. Walters, MD, MS, MBA
The University of Texas MD Anderson Cancer Center

Randal S. Weber, MD
The University of Texas MD Anderson Cancer Center

 


NCCN Foundation Board of Directors


The Honorable Ellen O. Tauscher / Chair
Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
Former Under Secretary of State for Arms Control & International Security and
Member of Congress

Michael Parisi, MBA, MS / Vice Chair
Ogilvy CommonHealth Worldwide

Ray Lynch, CPA, MBA / Treasurer
Huntsman Cancer Institute at the University of Utah

John A. Gentile, Jr. / Secretary
Harborside Press, LLC

Sam Donaldson / Chair Emeritus
ABC News

Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Joshua H. Bilenker, MD
Aisling Capital, LLC

Gena Cook
Navigating Cancer

Thomas A. D'Amico, MD
Duke Cancer Institute

Brian Garofalo
Patient Alliances

John S. Greene
Salesforce.com

William N. Hait, MD, PhD
Janssen Research & Development, LLC
Johnson & Johnson Pharmaceuticals Group

Deborah Morosini, MD
Foundation Medicine

Denise Reinke, MS, NP
University of Michigan Comprehensive Cancer Center
Sarcoma Alliance for Research through Collaboration (SARC)

Robert C. Young, MD
RCY Medicine
F
ormer President, Chief Executive Officer and Chancellor
of Fox Chase Cancer Center


Management Team


Robert W. Carlson, MDRobert W. Carlson, MD, is the Chief Executive Officer (CEO) at the National Comprehensive Cancer Network (NCCN). He joined NCCN as CEO in January 2013 following an esteemed history of leadership positions within the organization including, most notably, Representative to the NCCN Board of Directors, Chair of the Breast Cancer Guidelines Panel, Member and Founding Chair of the Breast Cancer Risk Reduction Guidelines Panel, and Chair of the Survivorship Guidelines Panel.

Prior to his appointment as CEO at NCCN, Dr. Carlson served as Professor of Medicine in the Division of Oncology and Stanford Medical Informatics at Stanford University Medical Center, as well as Medical Director of inpatient oncology and hematology at Stanford Cancer Institute in Stanford, California.

Dr. Carlson is a graduate of Stanford University Medical School, and he completed his internship and junior residency in internal medicine at Barnes Hospital Group in St. Louis, Missouri before returning to Stanford University to complete his senior residency. He earned a Bachelor of Science with distinction from Stanford University, specializing in biological sciences. Dr. Carlson is board certified in Medical Oncology and Internal Medicine.

Dr. Carlson is a member of several medical societies, including American College of Physicians (ACP), American Association for Cancer Research (AACR), and the American Society of Clinical Oncology (ASCO). Dr. Carlson lectures extensively and has authored or co-authored more than 140 articles, abstracts, and book chapters, which have appeared in publications such as Journal of the National Cancer Institute, Journal of Clinical Oncology, and The Breast Journal. He has served as Associate Editor of Oncology and JNCCN — Journal of the National Comprehensive Cancer Network.

From 2001 to 2012, Dr. Carlson was selected by America’s Top Doctors; from 1994 to 2011, he was selected by Best Doctors in America; in 2008, he was presented with the National Physician of the Year Award for Clinical Excellence by Castle Connolly Medical, Ltd.; and in 2010, Dr. Carlson was given the Founding Collaborator Award by the Breast Health Global Initiative (BHGI).


Gary J. Weyhmuller, MBA, SPHR

Gary J. Weyhmuller, MBA, SPHR, is the Executive Vice President/Chief Operating Officer (EVP/COO) at the National Comprehensive Cancer Network (NCCN). Mr. Weyhmuller joined NCCN as EVP/COO in February 2014. Working closely with the CEO, he is responsible for providing leadership and management to NCCN Staff, helping to assure the development of new programs, as well as the continued efficient and effective operations of existing programs for NCCN Member Institutions and other constituencies.

Mr. Weyhmuller comes to NCCN with more than 35 years of experience at Fox Chase Cancer Center, most recently serving as Senior Vice President and Chief Operating Officer, responsible for leadership and oversight of the daily operations supporting all research, clinical, and operational activities for more than 2,400 employees. Prior to this role as SVP/COO, Mr. Weyhmuller held several other leadership roles within Fox Chase, including Vice President of Human Resources and Chief Administrative Officer.

Mr. Weyhmuller holds a Master of Business Administration from LaSalle University and a Bachelor of Science in education, political science, and minority studies from West Chester University. He also holds a certification as Senior Professional in Human Resources (SPHR) from Villanova University.

Outside of his professional career Mr. Weyhmuller demonstrates an active history of community service. Currently he is Vice Chair of the Board of Directors for American Heritage Federal Credit Union and a member of the Board of Directors for United Cerebral Palsy of Philadelphia and Vicinity, where he served as President of the Board from 2008 through 2011.

Mr. Weyhmuller is active in a number of professional organizations including the Healthcare Financial Management Association (HFMA), the American Hospital Association (AHA), the Association of American Cancer Institutes (AACI), and the Society for Human Resource Management (SHRM). He has been recognized for his leadership, both professionally and through his community service, including the Fox Chase Cancer Center Inspired Leadership Award, recognition for leadership and personal dedication on behalf of people with disabilities from United Cerebral Palsy of Philadelphia and Vicinity, and the Greater Northeast Philadelphia Chamber of Commerce Crystal Vision Award.


Lisa G. Kimbro, CPA

Lisa G. Kimbro, CPA, MBA, is Senior Vice President, Finance/Chief Financial Officer for the National Comprehensive Cancer Network (NCCN). In this role, Ms. Kimbro manages NCCN's financial and business initiatives as well as provides leadership to its NCCN Best Practices Committee.

Ms. Kimbro has extensive experience in both academic and community-based health care. She served as Director of Managed Care for the University of South Florida Physicians Group, where she was actively involved in the organization's strategic planning initiatives and feasibility studies. In the community setting, she was the CFO of two dynamic and well-regarded physician groups in the Tampa Bay area. The responsibilities for those practices included (among others) business development, managed care contracting, financial reporting, patient accounting, compliance initiatives, and personnel management.

In addition to Ms. Kimbro's healthcare experience, she has worked in public accounting, most recently with Ernst & Young Global as a senior manager in Quality and Risk Management in its Paris, France office.

Ms. Kimbro completed her master's in Business Administration at the University of South Florida and her undergraduate degree at Florida State University. She is the co-author of the Governmental Accounting Standards Board Research Report, “The Needs of Users of Governmental Financial Reports.”


Joan S. McClure, MSJoan S. McClure, MS, is Senior Vice President of Clinical Information and Publications for the National Comprehensive Cancer Network (NCCN).  Ms. McClure's group develops the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), associated NCCN Guidelines for Patients®, the NCCN Drugs & Biologics Compendium(NCCN Compendium®), NCCN Chemotherapy Orders Templates (NCCN Templates®), the NCCN Biomarkers Compendium®, and JNCCN — Journal of the National Comprehensive Cancer Network. Ms. McClure also serves as an Associate Editor for JNCCN. The NCCN Guidelines® are a comprehensive set of guidelines detailing the sequential management decisions and interventions for 97 percent of malignant cancers affecting patients in the United States and for cancer prevention, screening, diagnosis and supportive care. Updated at least annually, the clinical practice guidelines are recognized as the standard for clinical policy in the United States and have served as a model for guidelines programs elsewhere in the world. Ms. McClure has led NCCN efforts to develop quality measures based on the NCCN Guidelines in collaboration with ASCO and Ingenix and to incorporate NCCN information into third party decision support systems aimed at improving quality care. 

Ms. McClure previously managed national oncology information programs for patients, health professionals, and the public on contracts with the U.S. National Cancer Institute (NCI) and supported the U.S. Food and Drug Administration in identifying and developing standards for medical and toxicology data used for submission to regulatory authorities in the United States, Europe, and Japan. She earned a MS degree from the University of Maryland, College Park.  


C. Lyn Fitzgerald, MJC. Lyn Fitzgerald, MJ, is Vice President, U.S. & Global Development at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Fitzgerald is charged with the development of U.S. and International business strategies. She serves as the key contact for Industry and oversees the NCCN Corporate Council and all permissions and licensing of NCCN content for commercial use.  Additionally, Ms. Fitzgerald provides oversight of the NCCN International Program, NCCN Communications & Marketing functions, the NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business, and NCCN Business Insights offerings, including:  NCCN Trends™, NCCN Oncology Insights Reports™, and NCCN Flash Updates™.

Prior to joining NCCN, Ms. Fitzgerald was a member of the Business Development team at the Nemours/Alfred I DuPont Hospital for Children, where she worked to develop and advance communication strategies for building and maintaining provider relationships. Ms. Fitzgerald was responsible for professional relations, including physician advocacy, and served as liaison to Nemours partner hospitals and to community practices, including providing educational programming and support.

From 1995 to 2001, Ms. Fitzgerald served as a Key Specialty Senior Representative at Schering-Plough Pharmaceuticals. Ms. Fitzgerald is a two-time Temple University graduate, earning a Bachelor of Business Administration in Economics from the Fox School of Business and a Master of Journalism from the School of Communications.  She is a published author of multiple articles on health and health care policy. 


Kristina  M. Gregory, RN, MSN, OCNKristina M. Gregory, RN, MSN, OCN, is Vice President of Clinical Information Operations at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Gregory is responsible for production of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). She also monitors and maintains tracking schedules representing the status of the NCCN Guidelines in the development process and web publication. Ms. Gregory also oversees production of NCCN Programs affiliated with the NCCN Guidelines®, including the NCCN Compendium® and NCCN Templates®.

Prior to working with NCCN, Ms. Gregory served as a Health Management Program Coordinator at Independence Blue Cross in Philadelphia, PA and was also a staff nurse at Fox Chase Cancer Center. Ms. Gregory is an active member of the National and Bucks/Montgomery Counties Chapter of the Oncology Nursing Society (ONS), the American Society of Clinical Oncology (ASCO), and a volunteer for the Leukemia and Lymphoma Society.

Ms. Gregory has a master's degree in Public Health Nursing from LaSalle University, and a B.S. in Nursing from the University of Pennsylvania. She is also a certified oncology nurse.


Diane E. Paul, MS, RN

Diane E. Paul, MS, RN, is Vice President of the Oncology Research Program at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Paul is responsible for developing and managing NCCN's centralized, standardized infrastructure for the conduct of clinical trials among its 25 NCCN Member Institutions. The Oncology Research Program fosters collaboration among NCCN Member Institutions and pharmaceutical and biotechnology companies to bring promising and effective new treatments to patients with cancer.

Prior to working with NCCN, Ms. Paul served as Executive Director of the Cancer Institute of New Jersey Oncology Group, and Director of the Cancer Institute of New Jersey Network at the University of Medicine and Dentistry of New Jersey in New Brunswick, New Jersey. Ms. Paul speaks often on such topics as cancer screenings and prevention and has published articles in clinical publications including Cancer Investigation, Cancer Practice, and Oncology Nursing Forum.

For her work with the Cancer Hope Network, Ms. Paul received an “Unsung Heroine Award” in 1988 – an honor sponsored by the Women's Network of New Jersey and presented by Senator Bill Bradley. She also received the Information Service Partnership Award from the National Cancer Institute in 1996. She is a recipient of Coping magazine's Hero Award and Mirabella's “1000 Points of Light” Award.

Ms. Paul completed her undergraduate degree in Nursing Science at the College of Saint Elizabeth in Convent Station, New Jersey, and her master's degree in Psychiatric/Mental Health Nursing at Rutgers University. She is a member of the Association of Cancer Executives, the American Society of Clinical Oncology and the Oncology Nursing Society.